High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study ...
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study ...
Recombinant Macrocyclic Lanthipeptides Incorporating Non-Canonical Amino Acids | Journal of the American Chemical Society
![Wenzel Dennig email address & phone number | Cmta Ag Chief Operations Officer and Chief Financial Officer contact information - RocketReach Wenzel Dennig email address & phone number | Cmta Ag Chief Operations Officer and Chief Financial Officer contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/kenneth-l-seibert-2a5f55e5.jpg)
Wenzel Dennig email address & phone number | Cmta Ag Chief Operations Officer and Chief Financial Officer contact information - RocketReach
Wenzel Dennig email address & phone number | Cmta Ag Chief Operations Officer and Chief Financial Officer contact information - RocketReach
![Teja TSCHARNTKE | Professor | Georg-August-Universität Göttingen, Göttingen | GAUG | Research profile Teja TSCHARNTKE | Professor | Georg-August-Universität Göttingen, Göttingen | GAUG | Research profile](https://i1.rgstatic.net/ii/profile.image/1140747180998659-1648986730358_Q512/Teja-Tscharntke-2.jpg)